In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex

Infections caused by the difficult-to-treat bacterium Mycobacterium abscessus are increasing in frequency. Rifabutin, in contrast to rifampin, appears to be active in vitro against M. abscessus, especially against clarithromycin-resistant strains. However, explorations for potential synergy between...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Cheng, Aristine, Tsai, Yi-Tzu, Chang, Shu-Yuan, Sun, Hsin-Yun, Wu, Un-In, Sheng, Wang-Huei, Chen, Yee-Chun, Chang, Shan-Chwen
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437537/
https://ncbi.nlm.nih.gov/pubmed/30670428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02234-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados